TRIGLIMISAVE-1TAB
Original price was: ₹194.96.₹175.46Current price is: ₹175.46.
Triglimisave-1TAB is a combination medication containing Glimepiride and Pioglitazone, used to control blood sugar levels in patients with type 2 diabetes.
Description
Triglimisave-1TAB is a medicine that contains a combination of Glimepiride and Pioglitazone. Glimepiride belongs to a class of drugs known as sulfonylureas and is used to treat type 2 diabetes mellitus. It helps to lower blood sugar levels by stimulating the release of insulin from the pancreas. Pioglitazone, on the other hand, is a thiazolidinedione that helps to improve insulin sensitivity in the body. This, in turn, helps to regulate blood sugar levels in individuals with type 2 diabetes. Triglimisave-1TAB is prescribed for individuals who are unable to control their blood sugar levels effectively with a single medication. The combination of Glimepiride and Pioglitazone provides a synergistic effect, enhancing the overall effectiveness of the treatment. The dosage and duration of use may vary depending on the individual’s condition and response to treatment.
Additional information
| Weight | 25 g |
|---|---|
| Marketed by | |
| Composition | |
| Dosage form | TABLET |
| Prescription | REQUIRED |
| Therapeutic use | ANTI DIABETICS |
Note: The actual product packaging may vary slightly from the images shown on our website. Due to manufacturer updates, there may be variations in packaging design. We strive to provide accurate representations of all products.
